These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 15920556)

  • 1. Breast carcinoma malignancy grading by Bloom-Richardson system vs proliferation index: reproducibility of grade and advantages of proliferation index.
    Meyer JS; Alvarez C; Milikowski C; Olson N; Russo I; Russo J; Glass A; Zehnbauer BA; Lister K; Parwaresch R;
    Mod Pathol; 2005 Aug; 18(8):1067-78. PubMed ID: 15920556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interobserver reproducibility of the Nottingham modification of the Bloom and Richardson histologic grading scheme for infiltrating ductal carcinoma.
    Frierson HF; Wolber RA; Berean KW; Franquemont DW; Gaffey MJ; Boyd JC; Wilbur DC
    Am J Clin Pathol; 1995 Feb; 103(2):195-8. PubMed ID: 7856562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation of proliferative index with various clinicopathologic prognostic parameters in primary breast carcinoma: A study from North India.
    Marwah N; Batra A; Marwah S; Gupta V; Shakya S; Sen R
    J Cancer Res Ther; 2018; 14(3):537-542. PubMed ID: 29893312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the prognostic value of Scarff-Bloom-Richardson and Nottingham histological grades in a series of 825 cases of breast cancer: major importance of the mitotic count as a component of both grading systems.
    Genestie C; Zafrani B; Asselain B; Fourquet A; Rozan S; Validire P; Vincent-Salomon A; Sastre-Garau X
    Anticancer Res; 1998; 18(1B):571-6. PubMed ID: 9568179
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prognostic effect of histological tumor grade in node-negative breast cancer patients.
    Schumacher M; Schmoor C; Sauerbrei W; Schauer A; Ummenhofer L; Gatzemeier W; Rauschecker H
    Breast Cancer Res Treat; 1993; 25(3):235-45. PubMed ID: 8369525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation of bromodeoxyuridine (BRDU) labeling of breast carcinoma cells with mitotic figure content and tumor grade.
    Weidner N; Moore DH; Ljung BM; Waldman FM; Goodson WH; Mayall B; Chew K; Smith HS
    Am J Surg Pathol; 1993 Oct; 17(10):987-94. PubMed ID: 8372950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Grading invasive ductal carcinoma of the breast: advantages of using automated proliferation index instead of mitotic count.
    Tawfik O; Kimler BF; Davis M; Stasik C; Lai SM; Mayo MS; Fan F; Donahue JK; Damjanov I; Thomas P; Connor C; Jewell WR; Smith H; Fabian CJ
    Virchows Arch; 2007 Jun; 450(6):627-36. PubMed ID: 17458558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitotic frequency as a prognostic factor in breast cancer.
    Biesterfeld S; Noll I; Noll E; Wohltmann D; Böcking A
    Hum Pathol; 1995 Jan; 26(1):47-52. PubMed ID: 7821916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathologic correlates of survival in 378 lymph node-negative infiltrating ductal breast carcinomas. Mitotic count is the best single predictor.
    Clayton F
    Cancer; 1991 Sep; 68(6):1309-17. PubMed ID: 1651805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of mitotic index, in vitro bromodeoxyuridine labeling, and MIB-1 assays to quantitate proliferation in breast cancer.
    Thor AD; Liu S; Moore DH; Edgerton SM
    J Clin Oncol; 1999 Feb; 17(2):470-7. PubMed ID: 10080587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of mitotic counts in the grading and prognosis of the breast cancer.
    Patel C; Sidhu KP; Shah MJ; Patel SM
    Indian J Pathol Microbiol; 2002 Jul; 45(3):247-54. PubMed ID: 12785160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of histologic grade nuclear components of Scarff-Bloom-Richardson (SBR). An improved score modification based on a multivariate analysis of 1262 invasive ductal breast carcinomas.
    Le Doussal V; Tubiana-Hulin M; Friedman S; Hacene K; Spyratos F; Brunet M
    Cancer; 1989 Nov; 64(9):1914-21. PubMed ID: 2551477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation of Ki-67 antigen expression with mitotic figure index and tumor grade in breast carcinomas using the novel "paraffin"-reactive MIB1 antibody.
    Weidner N; Moore DH; Vartanian R
    Hum Pathol; 1994 Apr; 25(4):337-42. PubMed ID: 8163266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of DNA cytometry in 281 premenopausal patients with lymph node negative breast carcinoma randomized in a control trial: multivariate analysis with Ki-67 index, mitotic count, and microvessel density.
    Mandard AM; Denoux Y; Herlin P; Duigou F; van De Vijver MJ; Clahsen PC; van Den Broek L; Sahmoud TM; Henry-Amar M; van De Velde CJ
    Cancer; 2000 Oct; 89(8):1748-57. PubMed ID: 11042570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mitotic figure recognition: agreement among pathologists and computerized detector.
    Malon C; Brachtel E; Cosatto E; Graf HP; Kurata A; Kuroda M; Meyer JS; Saito A; Wu S; Yagi Y
    Anal Cell Pathol (Amst); 2012; 35(2):97-100. PubMed ID: 21965283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction of node-negative breast cancer outcome by histologic grading and S-phase analysis by flow cytometry: an Eastern Cooperative Oncology Group Study (2192).
    Page DL; Gray R; Allred DC; Dressler LG; Hatfield AK; Martino S; Robert NJ; Wood WC
    Am J Clin Oncol; 2001 Feb; 24(1):10-8. PubMed ID: 11232942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of proliferative activity in breast cancer: MIB-1 immunohistochemistry versus mitotic figure count.
    Lehr HA; Hansen DA; Kussick S; Li M; Hwang H; Krummenauer F; Trouet S; Gown AM
    Hum Pathol; 1999 Nov; 30(11):1314-20. PubMed ID: 10571511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Application of the Scarff-Bloom-Richardson tumor grading system to fine-needle aspirates of the breast.
    Howell LP; Gandour-Edwards R; O'Sullivan D
    Am J Clin Pathol; 1994 Mar; 101(3):262-5. PubMed ID: 8135179
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up.
    Elston CW; Ellis IO
    Histopathology; 1991 Nov; 19(5):403-10. PubMed ID: 1757079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation between MIB-1 and other proliferation markers: clinical implications of the MIB-1 cutoff value.
    Spyratos F; Ferrero-Poüs M; Trassard M; Hacène K; Phillips E; Tubiana-Hulin M; Le Doussal V
    Cancer; 2002 Apr; 94(8):2151-9. PubMed ID: 12001111
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.